Renascience Inc. (TYO:4889)

Renascience Statistics

Total Valuation

Renascience has a market cap or net worth of JPY 36.42 billion. The enterprise value is 34.62 billion.

Market Cap	36.42B
Enterprise Value	34.62B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Renascience has 12.71 million shares outstanding.

Current Share Class	12.71M
Shares Outstanding	12.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	23.76%
Owned by Institutions (%)	5.08%
Float	9.69M

Valuation Ratios

The trailing PE ratio is 322.29.

PE Ratio	322.29
Forward PE	n/a
PS Ratio	275.90
PB Ratio	21.17
P/TBV Ratio	21.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	306.37
EV / Sales	262.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.39

Current Ratio	12.39
Quick Ratio	12.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 6.79% and return on invested capital (ROIC) is -6.08%.

Return on Equity (ROE)	6.79%
Return on Assets (ROA)	-5.65%
Return on Invested Capital (ROIC)	-6.08%
Return on Capital Employed (ROCE)	-10.41%
Revenue Per Employee	44.00M
Profits Per Employee	37.67M
Employee Count	3
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

In the past 12 months, Renascience has paid 30.00 million in taxes.

Income Tax	30.00M
Effective Tax Rate	20.98%

Stock Price Statistics

The stock price has increased by +738.87% in the last 52 weeks. The beta is 2.43, so Renascience's price volatility has been higher than the market average.

Beta (5Y)	2.43
52-Week Price Change	+738.87%
50-Day Moving Average	1,939.54
200-Day Moving Average	1,032.04
Relative Strength Index (RSI)	69.38
Average Volume (20 Days)	2,410,220

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Renascience had revenue of JPY 132.00 million and earned 113.00 million in profits. Earnings per share was 8.89.

Revenue	132.00M
Gross Profit	128.00M
Operating Income	-179.00M
Pretax Income	143.00M
Net Income	113.00M
EBITDA	-178.00M
EBIT	-179.00M
Earnings Per Share (EPS)	8.89

Balance Sheet

The company has 1.80 billion in cash and n/a in debt, giving a net cash position of 1.80 billion or 141.52 per share.

Cash & Cash Equivalents	1.80B
Total Debt	n/a
Net Cash	1.80B
Net Cash Per Share	141.52
Equity (Book Value)	1.72B
Book Value Per Share	135.31
Working Capital	1.72B

Cash Flow

Operating Cash Flow	-176.00M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 96.97%, with operating and profit margins of -135.61% and 85.61%.

Gross Margin	96.97%
Operating Margin	-135.61%
Pretax Margin	108.33%
Profit Margin	85.61%
EBITDA Margin	-134.85%
EBIT Margin	-135.61%
FCF Margin	n/a

Dividends & Yields

Renascience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.31%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Renascience has an Altman Z-Score of 26.14 and a Piotroski F-Score of 2.

Altman Z-Score	26.14
Piotroski F-Score	2